PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
5.86%
Revenue growth below 50% of CRWV's 23.55%. Michael Burry would check for competitive disadvantage risks.
73.68%
Cost growth above 1.5x CRWV's 19.16%. Michael Burry would check for structural cost disadvantages.
5.17%
Gross profit growth below 50% of CRWV's 25.15%. Michael Burry would check for structural issues.
-0.65%
Margin decline while CRWV shows 1.30% expansion. Joel Greenblatt would examine competitive position.
19.10%
R&D change of 19.10% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
10.89%
Operating expenses growth 50-75% of CRWV's 17.97%. Bruce Berkowitz would examine efficiency.
12.18%
Total costs growth 50-75% of CRWV's 18.28%. Bruce Berkowitz would examine efficiency.
No Data
No Data available this quarter, please select a different quarter.
-11.11%
D&A reduction while CRWV shows 26.15% growth. Joel Greenblatt would examine efficiency.
-1.59%
EBITDA decline while CRWV shows 33.05% growth. Joel Greenblatt would examine position.
-8.72%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
-0.21%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
-5.73%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
26.92%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
1.51%
Pre-tax income growth below 50% of CRWV's 9.63%. Michael Burry would check for structural issues.
-4.11%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
1.53%
Tax expense growth less than half of CRWV's 3.78%. David Dodd would verify if advantage is sustainable.
1.50%
Net income growth below 50% of CRWV's 7.67%. Michael Burry would check for structural issues.
-4.12%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.32%
Share count reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.
0.74%
Diluted share reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.